Evidence map›Paper›PMID 42289564›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026

Prognostic significance of the extent of extranodal extension in patients with pN1b papillary thyroid carcinoma: a retrospective cohort study.

Yunhe Liu, Xiwei Zhang, Jie Liu, Song Ni, Hui Huang, Shaoyan Liu

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yunhe LiuDepartment of Head and Neck Surgical Oncology, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, China.
Xiwei ZhangDepartment of Head and Neck Surgical Oncology, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, China.
Jie LiuDepartment of Head and Neck Surgical Oncology, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, China.
Song NiDepartment of Head and Neck Surgical Oncology, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, China.
Hui HuangDepartment of Head and Neck Surgical Oncology, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, China. huanghuinj@163.com.ORCID http://orcid.org/0000-0002-1301-6226
Shaoyan LiuDepartment of Head and Neck Surgical Oncology, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe literature has revealed considerable discrepancies in the nodal extension (ENE) definition and risk stratification. This study aimed to assess the extent of ENE in patients with lateral cervical lymph node metastases (pN1b) and evaluate its relationship with survival outcomes.

methodsA retrospective cohort analysis was conducted involving patients with pN1b PTC who underwent initial surgery between January 2000 and December 2018. Disease-specific survival (DSS) was analyzed using Kaplan-Meier survival curves, and compared using the log-rank test. The association between the extent of ENE and DSS was examined using Cox proportional hazards regression models.

resultsThe study included 3,382 patients. Microscopic ENE (miENE) was identified in 808 patients (23.9%). Macroscopic ENE (maENE) was divided into maENEa (499 patients, 14.8%) and maENEb (84 patients, 2.5%). The overall 5-year DSS rate was 98.9%. Stratification by ENE extent revealed 5-year DSS rates of 99.8% for no ENE, 99.5% for miENE, 97.5% for maENEa, and 82.2% for maENEb, indicating significant differences (p < 0.001). Cox regression analysis for DSS revealed significant associations with ENE extent, showing adjusted hazard ratios (HRs) of 3.49 (95% CI 1.28-9.51; P = 0.015) for the miENE group, 4.54 (95% CI 1.73-11.88; P = 0.002) for the maENEa group, and 20.54 (95% CI 7.95-53.10; p < 0.001) for the maENEb group, compared to the no-ENE group.

conclusionThe prognostic significance of ENE in PTC is highly variable and contingent on its extent. We propose stratification of maENE into maENEa and maENEb, with distinct DSS outcomes.

Indexed as

Extranodal ExtensionLymph NodesThyroid Cancer, PapillaryThyroid NeoplasmsAdultAgedFemaleHumansLymphatic MetastasisMaleMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesSurvival RateThyroidectomyDisease-specific survivalExtranodal extensionLymph node metastasisPapillary thyroid carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.